Skip to content

Efficacy of Respiratory Physiotherapy Treatment in Chronic Obstructive Disease.

Efficacy of Respiratory Physiotherapy Treatment in Patients With Chronic Obstructive Disease in Elderly Patients.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07204431
Enrollment
60
Registered
2025-10-02
Start date
2025-08-01
Completion date
2025-09-24
Last updated
2026-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

diaphragmatic expiratory exercises., physiotherapy tecniques

Brief summary

To test the effectiveness of a respiratory physiotherapy treatment plan in patients who have been diagnosed with chronic obstructive pulmonary disease, comparing with two randomized groups, for the performance of different respiratory musculature training protocols. Objectify the data obtained through ultrasound and spirometry, observing the differences obtained at the beginning and end of the study, verifying the efficacy of the PowerBreathe® and Therosold PEP® tools and the effectiveness of diaphragmatic, abdominal and expiratory exercises.

Interventions

DEVICEthe PowerBreathe and PEP Therosold tools group.

Initially, the following data were collected from each subject in addition to basic epidemiological data.

Sponsors

Universidad Católica de Ávila
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with chronic obstructive disease. * Patients older than 65 years. * Patients under age. * Patients with cognitive ability to perform spirometry. * Patients with physical ability to perform spirometry.

Exclusion criteria

* Patients without functional limitations in the respiratory system. * Patients under 65 years of age. * Patients with no cognitive ability to perform spirometry. * Patients without physical ability to perform spirometry.

Design outcomes

Primary

MeasureTime frameDescription
peak inspiratory pressure (PIM).1 month.0 miminum ,200 maximum.
peak expiratory pressure.1 month.0 miminum ,200 maximum.
forced vital capacity.1 month.0 miminum ,200 maximum.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026